» Articles » PMID: 23643712

Inhibition of N-acetylglutamate Synthase by Various Monocarboxylic and Dicarboxylic Short-chain Coenzyme A Esters and the Production of Alternative Glutamate Esters

Overview
Specialties Biochemistry
Biophysics
Date 2013 May 7
PMID 23643712
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperammonemia is a frequent finding in various organic acidemias. One possible mechanism involves the inhibition of the enzyme N-acetylglutamate synthase (NAGS), by short-chain acyl-CoAs which accumulate due to defective catabolism of amino acids and/or fatty acids in the cell. The aim of this study was to investigate the effect of various acyl-CoAs on the activity of NAGS in conjunction with the formation of glutamate esters. NAGS activity was measured in vitro using a sensitive enzyme assay with ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) product analysis. Propionyl-CoA and butyryl-CoA proved to be the most powerful inhibitors of N-acetylglutamate (NAG) formation. Branched-chain amino acid related CoAs (isovaleryl-CoA, 3-methylcrotonyl-CoA, isobutyryl-CoA) showed less pronounced inhibition of NAGS whereas the dicarboxylic short-chain acyl-CoAs (methylmalonyl-CoA, succinyl-CoA, glutaryl-CoA) had the least inhibitory effect. Subsequent work showed that the most powerful inhibitors also proved to be the best substrates in the formation of N-acylglutamates. Furthermore, we identified N-isovalerylglutamate, N-3-methylcrotonylglutamate and N-isobutyrylglutamate (the latter two in trace amounts), in the urines of patients with different organic acidemias. Collectively, these findings explain one of the contributing factors to secondary hyperammonemia, which lead to the reduced in vivo flux through the urea cycle in organic acidemias and result in the inadequate elimination of ammonia.

Citing Articles

Complex I activity in hypoxia: implications for oncometabolism.

Chinopoulos C Biochem Soc Trans. 2024; 52(2):529-538.

PMID: 38526218 PMC: 11088919. DOI: 10.1042/BST20230189.


Hyperammonemia and inborn errors of metabolism.

Corado A Transl Pediatr. 2024; 13(2):200-202.

PMID: 38455740 PMC: 10915440. DOI: 10.21037/tp-23-593.


The glycine -acyltransferases, GLYAT and GLYATL1, contribute to the detoxification of isovaleryl-CoA - an and validation.

Kuhn S, Williams M, Dercksen M, Sass J, van der Sluis R Comput Struct Biotechnol J. 2023; 21:1236-1248.

PMID: 36817957 PMC: 9932296. DOI: 10.1016/j.csbj.2023.01.041.


Clinical and biochemical footprints of inherited metabolic disorders. XI. Gastrointestinal symptoms.

Salazar D, Kloke K, Bonilla Guerrero R, Ferreira C, Blau N Mol Genet Metab. 2023; 138(3):107528.

PMID: 36774919 PMC: 10509718. DOI: 10.1016/j.ymgme.2023.107528.


Toxic Metabolites and Inborn Errors of Amino Acid Metabolism: What One Informs about the Other.

Lee N, Kim D Metabolites. 2022; 12(6).

PMID: 35736461 PMC: 9231173. DOI: 10.3390/metabo12060527.